Related Content
July 5, 2017 — Bayer has enrolled the first patient in a global Phase IV study assessing the clinical effects of ...
Here are several updates in medical imaging contrast media agents. Two of the biggest news items were related to safety ...
March 30, 2017 — The Connecticut Hospital Association (CHA) and Bayer announced an alliance to establish the United ...
January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source ...
Healthcare organizations, clinicians and medical equipment manufacturers have long focused on the management and ...
April 29, 2016 — Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) ...
April 13, 2016 — The global market for contrast media is set to rise from just over $4.3 billion in 2015 to over $6 ...
September 4, 2015 — Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from ...
March 10, 2015 — The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the ...
Cardiac imaging accounts for about one-third of the source of X-ray radiation dose for all medical imaging. Expanding ...